[¹⁷⁷Lu]Lu-DOTATATE Molecular Radiotherapy During Induction Chemotherapy for First-Line Stage 4 High-Risk Neuroblastoma in South African Children: Protocol for a Phase 1 Randomized Controlled Trial (LuDO-SA Trial)

[177Lu]Lu-DOTATATE Molecular Radiotherapy During Induction Chemotherapy for First-Line Stage 4 High-Risk Neuroblastoma in South African Children: Protocol for a Phase 1 Randomized Controlled Trial (LuDO-SA Trial)

Authors of this article:

Jaques van Heerden^{1, 2} ;   Mariana Kruger^{1, 3} ;   Kershinee Reddy^{4, 5} ;   Anel van Zyl¹ ;   James Warwick⁶ ;   Celeste Burger⁶ ;   Tumelo Moalosi⁶ ;   Christoffel van Reenen⁶ ;   Alan Davidson⁷ ;   Khanyisile Hlongwa⁸ ;   Daniella Violante^{8, 9} ;   Nanette Bruwer⁶ ;   Gita Naidu¹⁰ ;   Biance Rowe¹⁰ ;   Lizette Louw¹¹ ;   Bronwin van Wyk¹² ;   Mariza Vorster¹³ ;   Thokozani Mkhize¹³ ;   Anita Brink¹⁴